CAJ | 학술논문

目的总结分析股浅动脉粥样硬化狭窄闭塞病变置入Viabahn腔内人工血管的初期疗效.方法回顾性分析2013年3-11月收治的因症状性股浅动脉硬化狭窄或闭塞而置入Viabahn腔内人工血管45例患者(54条肢体)临床资料,观察术后l、3、6个月的通畅率、临床分级改善程度、踝肱比变化、保肢率及生存率.结果最终完成43例患者(52条肢体)的随访数据收集,其中TASCⅡC型及D型病变32例(38条肢体).52条肢体治疗段长度为13.3～32.5cm,平均长度为(19±4) cm;血管超声随访通畅率:术后1、3、6个月分别为96.15％(50条肢体)、92.31％(48条肢体)和90.38％(47条肢体);踝肱比变化:术前平均0.32±0.20升至术后平均0.68 ±0.18(t =3.180,P ＜0.005);术后6个月保肢率为96.08％(49条肢体),生存率为97.67％(42例).结论对于股浅动脉粥样硬化狭窄或闭塞性病变,使用Viabahn腔内人工血管初期疗效确切,可作为安全的治疗方案选择.
목적 총결분석고천동맥죽양경화협착폐새병변치입Viabahn강내인공혈관적초기료효.방법 회고성분석2013년3-11월수치적인증상성고천동맥경화협착혹폐새이치입Viabahn강내인공혈관45례환자(54조지체)림상자료,관찰술후l、3、6개월적통창솔、림상분급개선정도、과굉비변화、보지솔급생존솔.결과 최종완성43례환자(52조지체)적수방수거수집,기중TASCⅡC형급D형병변32례(38조지체).52조지체치료단장도위13.3～32.5cm,평균장도위(19±4) cm;혈관초성수방통창솔:술후1、3、6개월분별위96.15％(50조지체)、92.31％(48조지체)화90.38％(47조지체);과굉비변화:술전평균0.32±0.20승지술후평균0.68 ±0.18(t =3.180,P ＜0.005);술후6개월보지솔위96.08％(49조지체),생존솔위97.67％(42례).결론 대우고천동맥죽양경화협착혹폐새성병변,사용Viabahn강내인공혈관초기료효학절,가작위안전적치료방안선택.
Objective To observe the primary clinical results of Gore （R） Viabahn endoprosthesis for atherosclerotic stenosis or occlusion in superficial femoral artery (SFA).Methods From March 2013 to November 2013,45 consecutive patients (54 limbs) who had ischemic symptom due to stenosis or occlusion of superficial femoral artery were treated by endovascular deployment of Gore （R） Viabahn endoprosthesis.We observed patency rate,improvement of Rutherford classification and ankle-brachial index,limb salvage rate and survival rate after 1,3 and 6 months.Results 43 patients (52 limbs)were followed-up,among which 32 patients(38 limbs)belonged to TASC Ⅱ type C or type D lesion.The mean (± SD) length of treated segment in 52 limbs was(19 ±4)cm.The rate of postoperative patency on duplex ultrasonography:one month,3 months and 6 months were 96.15％ (50 limbs),92.31％ (48 limbs)and 90.38％ (47 limbs) ; Ankle-brachial index increased from(0.32 ±0.20)to(0.68 ±0.18) (t =3.180,P ＜ 0.005) after 6 months ; at 6 months limb salvage rate was 96.08 percent (49 limbs),and survival rate was 97.67％ (42 patients).Conclusions Implantation of Gore （R） Viabahn endoprosthesis in atherosclerotic stenotic or occluded superficial femoral artery safely achieves a definite primary clinical effectiveness.